ACEA Therapeutics, Inc. — Form D
ACEA Therapeutics, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2018-03-12. The offering totals $15.0M, of which $7.9M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2018-03-12
- Form: D
- Accession: 0001734186-18-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $15.0M
- Amount sold: $7.9M
- Remaining: $7.1M
- Investors: 3
- Date of first sale: 2018-02-22
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-307453
Issuer
- Name: ACEA Therapeutics, Inc.
- CIK: 0001734186
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 6779 MESA RIDGE ROAD, SUITE #100, SAN DIEGO, CA, 92121
- Phone: 858-299-8001
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Lin Li | Director | Central, K3 |
| Xiao Xu | Director | San Diego, CA |
| Xiao Xu | Executive Officer | San Diego, CA |
| Joyce Hsu | Director | San Diego, CA |
| Jixun Lin | Director | San Diego, CA |
| Ng Chi Keung | Director | San Diego, CA |
| Mang Yu | Director | San Diego, CA |
| Stephen Lin | Director | San Diego, CA |
| Feng Lin | Director | San Diego, CA |
| Xiaobo Wang | Director | San Diego, CA |
| Xiaobo Wang | Executive Officer | San Diego, CA |
Other filings by this issuer (1)
More